CHINA, ZHUHAI, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Recently, VTR Biotech proudly announces the comprehensive upgrade of its National Enterprise Technology Center, a landmark achievement reflecting ...

CHINA, ZHUHAI, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Recently, VTR Biotech proudly announces the comprehensive upgrade of its National Enterprise Technology Center, a landmark achievement reflecting its ...

In a report released today, James Kammert from Evercore ISI reiterated a Buy rating on Ventas (VTR – Research Report), with a price target of $72.00. The company’s shares closed last Friday at ...

On October 31, 2024, Ventas Inc (NYSE:VTR), a real estate investment trust specializing in healthcare properties, released its 10-Q filing, revealing the company's financial performance for the ...

Louisiana State Employees Retirement System increased its stake in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 1.7% during the third quarter, according to the company in its most recent ...

SHOP Same Store Cash NOI Guidance: 15% growth year-over-year at the midpoint. Ventas Inc (NYSE:VTR) reported a strong third quarter with a 7% year-over-year increase in normalized FFO per share, ...

Shares of NYSE VTR opened at $64.19 on Monday. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.04 and a quick ratio of 0.58. The stock has a market capitalization of $26.52 ...

Threats: Rising interest expenses and regulatory challenges in the healthcare sector. On October 31, 2024, Ventas Inc (NYSE:VTR), a real estate investment trust specializing in healthcare properties, ...

Buy VTR near 61.49 target 66.89 stop loss @ 61.31 Details The technical summary data tells us to buy VTR near 61.49 with an upside target of 66.89. This data also tells us to set a stop loss @ 61.31 ...

Moreover, the 36-month beta value for VTR is 1.41. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 14 as “hold,” and 4 as “sell.” The public float ...